Side Effects and Disease-Free Survival with Capecitabine Compared to 5FU for Concurrent Radiochemotherapy of Rectal Cancer: A 5-year Review
Background: Considering the ease of administration of capecitabne instead of infusional 5FU for concurrent radiochemotherapy (RcT) of rectal cancer, the use of capecitabine has increased significantly in our radiation oncology department in the past years. Thus we decided to compare the safety and...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2014-01-01
|
| Series: | Basic & Clinical Cancer Research |
| Subjects: | |
| Online Access: | https://bccr.tums.ac.ir/index.php/bccrj/article/view/92 |